An update of international guidelines for the evaluation and management of chronic kidney disease;Un aggiornamento delle linee guida internazionali per la valutazione e la gestione della malattia renale cronica

Biochimica Clinica

Volumn 38, Issue 1, 2014, Pages 32-38

  Graziani, Maria Stella ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893835314     PISSN: 03930564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Supp 2013;3:1-150.
2. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.
3. Schünemann HJ, Oxman AD, Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. Br Med J 2008;336:1106- 10.
4. American Diabetes Association. Position statement. Nephropathy in diabetes. Diabetes Care 2004;27:S79-83.
5. American Diabetes Association. Standards of medical care in diabetes 2013. Diabetes Care 2013;36:S11-66.
6. Miller WG, Bruns DE, Hortin GL, et al. Principali aspetti nella misurazione e refertazione della escrezione urinaria di albumina. Biochim Clin 2010;34:337-50.
7. Graziani MS, Caldini A per il Gruppo di Studio Intersocietario SIBioC-SIMeL Diabete Mellito. Indicazioni per la misura dell'albumina nelle urine per l'accertamento e il monitoraggio della nefropatia diabetica. Biochim Clin 2011;35:127-30.
8. Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009;20:629-37.
9. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-12.
10. Levey AS, Gassman JJ, Hall PM, et al. Assessing the progression of renal disease in clinical studies: effects of duration of follow-up and regression to the mean. Modification of Diet in Renal Disease (MDRD) Study Group. J Am Soc Nephrol 1991;1:1087-94.
11. Inker LA, Eckfeldt J, Levey AS, et al. Expressing the CKDEPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis 2011;58:682-4.
12. Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012;367:20-9.
13. Stevens LA, Schmid CH, Greene T, et al. Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis 2010;56:486-95.
14. van den Brand JA, van Boekel GA, Willems HL, et al. Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population. Nephrol Dial Transplant 2011;26:3176-81.
15. Earley A, Miskulin D, Lamb EJ, et al. Estimating equations for glomerular filtration rate in the era of creatinine standardization. A systematic review. Ann Intern Med 2012;156:785-95.
16. Infusino I, Panteghini M. Riferibilità metrologica e validità della determinazione della creatinina come indice di funzionalità renale. Biochim Clin 2007;31:13-8.
17. Ceriotti F. Determinazione della creatinina: per i laboratori è tempo di agire. Biochim Clin 2010;34:9.
18. Carobene A, Ceriotti F, Infusino I, et al. Valutazione dell'impatto del processo di standardizzazione sulla qualità della misura della creatininemia nei laboratori italiani. Biochim Clin 2012;36:414-24.
19. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992;38:1933-53.
20. Seronie-Vivien S, Delanaye P, Pieroni L, et al. Cystatin C: current position and future prospects. Clin Chem Lab Med 2008;46:1664-86.
21. Grubb A, Blirup-Jensen S, Lindström V, et al. First certified reference material for cystatin C in human serum ERMDA471/ IFCC. Clin Chem Lab Med 2010;48:1619-21.
22. Zegers I, Blirup-Jensen S, Althaus H, et al. Preliminary commutability study on a candidate reference material for cystatin C. Clin Chem 2010;56:A99.
23. Ferrero CA, Magro F, Portaluppi S, et al. ERM/DA 471: experience of restandardization of Sentinel cystatin C assay. Biochim Clin 2010;34:525.
24. Villa C, Scarsi G. Imprecisione e stima degli intervalli di riferimento con un metodo immunoturbidimetrico per la misura della cistatina C. Biochim Clin 2011;35:329-30.
25. Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol 2009;20:2305-13.
26. Saydah SH, Pavkov ME, Zhang C, et al. Albuminuria prevalence in first morning void compared with previous random urine from adults in the National Health and Nutrition Examination Survey, 2009-2010. Clin Chem 2013;59:675-83.
27. Lieske JC, Bondar O, Miller WG, et al. A reference system for urinary albumin: current status. Clin Chem Lab Med 2013;51:981-9.
28. Coresh J for Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010;375:2073-8.